Juvenescence capitalizes BYOMass
March 27, 2019
Juvenescence is pleased to announce its latest equity investment in BYOMass Inc., a Massachusetts-based company focused on central control of metabolism in the context of aging and age-related diseases. Juvenescence will provide BYOMass with up to $6.5 million in equity financing and collaborate with BYOMass to advance these programs.
Juvenescence is also delighted to announce that
"Chronic disease is a tremendous burden on our healthcare system and economy, we are excited by the potential for byomass to make an impact this colossal problem", said
Dr. Jackson said, "I am delighted to join Juvenescence and advance their mission helping people live longer, healthier lives. I am also excited that BYOMass's therapeutic programs will benefit from the ecosystem Juvenescence is building to accelerate the discovery and development of novel therapeutics."
ABOUT JUVENESCENCE LTD.
Juvenescence Limited is a life sciences company developing therapies to increase healthy human longevity. It was founded by
Link the Business Wire press release found here.